Symposia: Osteoporosis, Nutrition and Fragility Fracture Flashcards

1
Q

What causes people to break their bone?

  • specific biological factors
A
  • Bone strength is reduced
    • Suboptimal peak bone mass
    • Reduced bone quality
      • Reduced bone Mineral ( Calcium )
      • Deteriorating architecture
      • Change in crystal size & composition
      • Abnormal collagen
  • Falls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What factors can increase peak bone mass?

A
  • Excercise
  • Diet
  • Sex hormones
    • oestrogen deficiency –> osteoporosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Osteogenesis Imperfecta?

A
  • a genetic defect where collagen (the protein that is responsible for bone structure) is missing, reduced or of low quality, so is not enough to support the minerals in the bone.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What factors need to be considered in the history/ examination when considering fracture risks in older people?

A
  • Age
  • Previous Fracture
  • Lightweight ( BMI < 18 )
  • Family History
  • Smoking
  • Alcohol
  • Medical Disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What Medical disorders increase fracture risks?

A
  • Osteogenesis imperfecta
    • underproduction of collagen
  • Cushing’s Syndrome
  • treatment with Glucocorticoids/ steroids
  • those with Inflammatory conditions
    • Rheumatoid nodules
    • Rheumatoid arthritis
  • Prostate cancer - treatment with Androgen Deprivation Therapy
    • low levels of testosterone reduces bone density similar to women going through menopause
  • Chronic respiratory disease - treatment with steriods and reduced physical activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What nutritional factors impact bone health?

A
  • Cows milk—source of calcium, magnesium, Vitamin D, protein and fat - good ‘bone’ food.
    • Soya milk—bioavailability of calcium requires a higher level of fortification than that naturally seen in cows milk. Bioavailability may be compromised in some products.
  • Balance of magnesium and calcium important—excess calcium depletes magnesium.
  • Protein - diets high in protein can lead to a reduction of calcium but studies
    • fractures neck of the Femur indicates improved bone healing in diets with high protein intake. Meta-analysis suggests no benefits from plant sources
  • Vitamin D
  • PUFA
  • Gluten intolerance- gliadin and phytate are linked to reduced calcium absorption
  • Phytate creates insoluble complexes with calcium
  • Oxalate also inhibits bioavailability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can bone health be managed in osteoporosis?

A
  • Calcium—benefit seen in children in the short term.
    • Postmenopausal women no effect on bone density but an effect on bone loss.
    • Should be supplemented with Vit D +ve result
  • Vitamin K effect on osteocalcin, protein involved in bone mineralisation, enhances ability to bind calcium
    • having a good microbiome in the colon benefits the activity
  • Sodium—reduces intake in diey. causes increased calcium urinary loss seen when sodium intake high
  • Phyto oestrogens - under investigation, some benefit seen where habitual intakes are high (regularly take soy products
  • Strontium—stable strontium in low doses has been shown to increase bone formation and decreases done resorption
  • EFA’s ALA [Omega 3] and LA [Omega 6] provide substrates for eicosanoids—prostaglandins, leukotrienes and thromboxanes. Dietary ratio affects bone formation and resorption. Omega 3 (alpha linolenic acid) reduces bone resorpion. Omega 6 (Linoleic acid ) increases bone resorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a clear physical sign of vertebral fractures?

A
  • having a curved spine
  • not often diagnosed presents as chronic back pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinically relevant sites that are scanned during a DEXA scan?

A
  • Lumbar spine (L1-L4)
  • Hip
  • Forearm (hyper[arathyroidism, non-diagnostic spine or hip)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What do BMD measurements from DEXA scans indicate about the bone health of a patient?

A
  • For post-menopausal women and men over 50 WHO:
  • T-score:
  • Normal =equal or greater than -1
  • Osteopenia=T score between -1 and -2.5
  • Osteoporosis= T score equal to or below -2.5.
  • Z score of < -2.0 means BMD is lower than it should be for someone age matched.
  • For diagnostic purposes the lowest score should be used (any of total spine, total hip, NOF or total forearm).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the traditional diagnosis of Osteoporosis? What measurements are taken?

A
  • DEXA (dual-energy X-ray absorptiometry) scan - it uses low dose X-rays to measure bone mass per area (g/cm2)
    • osteoporosis is diagnosed when T-score is -2.5 SD below the Bone Mineral Density (BMD) of a young healthy adult
    • a Z-score can also be measured which is the SD between the measured BMD and that of someone of the same age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What factors are used to generate the FRAX tool? (12)

A
  1. Age
  2. Sex
  3. Weight
  4. Height
  5. Previous fracture
  6. Parent Fractured Hip
  7. Current Smoking
  8. Glucocorticoids
  9. Rheumatoid arthritis
  10. Secondary Osteoporosis
  11. Alcohol 3 or more units/day
  12. Femoral neck BMD (g/cm2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the Bone Health Assessment Tools in the UK?

A
  • FRAX score
    • uses the femoral neck BMD on DEXA with clinical risk factors to calculate the 10yr probability of a major osteoporotic fracture or of hip fracture
  • Q Fracture Risk Calculator
    • Estimates the 1-10 year cumulative incidence of hip or major osteoporotic fracture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What significance does the site of a fracture have?

A
  • All fragility fractures increase future fracture risk independent of BMD - but some more than others.
  • Fractures of the hip and spine carry a higher risk for recurrent fracture than fractures of the distal radius.
    • vertebral fractures have a 5-fold increased risk of fracture in the year following
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What algorithm is used to assess absolute risk using a FRAX

(flow chart pathway)

A
  • High risk → treat immediately
  • Intermediate risk → DEXA scan reassess probability
  • Low → monitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does a Trabecular Bone score indicate

A
  • High TBS → strong, fracture-resistant microarchitecture
  • Low TBS → weak, fracture-prone microarchitecture

→ TBS decreases with age from ~45 years, can be used to compute FRAX score adjusted for TBS which s more accurate

17
Q

What is the Trabecular Bone Score?

A
  • Derived from the textural analysis of the DEXA spine image by computer software. Quantifies variation in grey-level texture.
    • Related to 3D bone micro-architecture (trabecular number, separation and density).
  • Provides fracture risk assessment independent of BMD, FRAX, clinical risk factors.
  • Can also input into the FRAX tool to provide better fracture risk assessment.
18
Q

What is a High-Resolution Peripheral CT (HRpQCT) and when is it used?

A
  • Mainly research setting.
  • Sensitive 3-D high-resolution CT of the peripheries (wrist and ankle).
  • Achieves higher spatial resolution than conventional CT at a low dose (5 µSv/cm).
  • Provides quantitative volumetric bone mineral density (vBMD, g/cm3) rather than areal BMD (DEXA).
  • Can assess bone micro-architecture (separate cortical and trabecular bone assessment).
  • Cortical bone- thickness, density and porosity.
  • Trabecular bone-trabecular thickness, number and separation.
  • Provides information previously only obtained from a bone biopsy.
19
Q

What advice on Calcium is given to patients with osteoporosis?

  • what are the guidelines for adults and adolescents?
A
  • Advised a daily Calcium intake 700mg/d to1200mg/d for prevention and treatment
  • If on Bone medicines and cannot obtain dietary >700mgs then supplement (NOGG 2017)
  • RNI: 700 mg/d per adult
  • 800mg/d(F) to 1000mg/d(M) Adolescents
20
Q

What is the exercise strategy for reducing secondary fractures?

A
  • STRONG, STRAIGHT STEADY
  • STRONG
    • exercise and physical activity that will strengthen bones safely
  • STRAIGHT
    • moving, lifting and living safely with osteoporosis
    • help with pain and posture after spinal fractures
  • STEADY
    • balance and muscle strength to stop you falling
21
Q

What are treatments for osteoporosis?

  • side effects?
A
  • Bisphosphonates
    • oral Alendronate, oral Risedronate, oral Ibandronate
    • IV Zoledronate
      • can be taken annually possibly up to 2 years
    • Jaw Osteonecrosis happens in 1/10000 after long term use
  • Denosumab - human monoclonal antibody
  • Anabolic Treatment- PTH
  • Romososumab - human anti-sclerostin recombinant antibody
  • Nebido - testosterone injection
22
Q

How do you take Oral Bisphosphonates?

  • what is the clinical significance of not taking it properly?
A
  • Take
    • In the morning
    • With a full glass of water
    • Standing up
  • Do not lie down after
  • No food for 30 minutes
    • Food inhibits absorption
    • calcium binds to the bisphosphonates
  • causes mouth ulcers as it’s very acidic
23
Q

What is the action of Bisphosphonates?

A
  • Inhibit Osteosclast action by inhibiting an important enzyme
  • Bisphosphonates inhibit bone resorption by selective adsorption to mineral surfaces and subsequent internalization by bone-resorbing osteoclasts where they interfere with various biochemical processes
  • non–nitrogen-containing bisphosphonates (eg, clodronate and etidronate) can be metabolically incorporated into nonhydrolysable analogues of adenosine triphosphate (ATP) that may inhibit ATP-dependent intracellular enzymes
24
Q

What is Denosumab?

A
  • a monoclonal antibody
  • IgG2 isotype
  • Binds to RANK Ligand which prevents osteoclast activation
    • Decoy Receptor
    • High affinity + High specificity
    • No complement activation
  • Rapidly absorbed
  • Long half-life
    • 26 days ( 34 days with max dose )
    • 6 monthly injection
  • Cleared by Reticuloendothelial system
    • No renal excretion
  • Reduces spine & Hip Fractures
25
Q

What do Anabolic Treatment for Osteoporosis do?

A
  • a s/c Para Thyroid Hormone 1-34
    • increases calcium deposition in the bone - increase bone formation
  • Daily s/c Injection
  • Pulse of PTH
    • Anabolic to bone
  • Reduces Fractures
    • Vertebral
    • Non-vertebral
26
Q

What is Romsosoumab?

  • when is it used
  • dose?
  • contraindications
A
  • Human Anti-Sclerostin Recombinant Antibody
    • this inhibits Sclersostin which inhibits osteoblast activation
    • increases osteoblast activity –> bone formation
  • used in Postmenopausal women with Osteoporosis
  • 210 mg s/c monthly for 12 months
    • Two consecutive 105 mg injections at different injection sites
  • Contraindications
    • Previous Stroke or myocardial infarction
27
Q

What are the anti-remodelling drugs used to prevent fractures

A
  • ALENDRONATE (weekly)
  • RISEDRONATE (weekly)
  • ZOLENDRONATE IV ( annually)
  • DENOSUMAB s/c ( 6 monthly )
  • HRT ( Not Tibolone ))
28
Q

What are the available Anabolic drugs with evidence from treating

A
  • Teriparatide ( PTH 1-34 )
  • Abaloparatide ( not licenced in UK )
    • PTH / PTHRP analogue
  • Rososumab
    • Antisclerostin antibody
    • Increases Wnt Signaling in bone
      • increased ostablast activity
29
Q

What bone material properties increase the risk of fragility fractures?

A
  • Mutations in type 1 collagen: insufficient quantity of collagen or abnormal collagen
  • Altered hydroxyapatite crystal structure
  • advanced glycation end products (AGE) in diabetes
30
Q

What is Densosumab and what is its action?

A
  • Used to manage osteoporosis in high-risk individuals of fractures
  • IgG2 isotype
  • inhibits to RANKL ligand
  • prevents RANKL from activating its receptor, RANK, on the surface of osteoclasts and their precursors.
    • Prevention of the RANKL/RANK interaction inhibits osteoclast formation, function, and survival, thereby
    • decreasing bone resorption and increasing bone mass and strength in both cortical and trabecular bone
  • has a long half-life → 6 monthly injections 60mg S/C
  • cleared by the reticuloendothelial system no renal excretion
31
Q

What is Primary Osteoporosis?

A
  • Incidence in women is greater than in men
  • Type 1-post menopausal
  • Type 2 - senile (70-75y/o)
32
Q

What is secondary Osteoporosis?

A
  • Incidence in male and female is equal
  • Chronic predisposing medical disease e.g. Rheumatoid, anorexia.
  • Prolonged use of medications e.g. steroids, aromatase inhibitors, anti-epileptics, thyroxine, proton pump inhibitors.